FDA National Drug Codes
Searching…
FDA National Drug Codes
Searching…
FDA National Drug Codes
Browse every product in the FDA NDC Directory below, or search by NDC, brand, generic, manufacturer or HCPCS code. Each product has its own page with package NDCs in 11-digit billing format.
7,911 products (finished products)
| Product | Strength | Form · route | Labeler | Application | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|---|---|
| Powerfulx Ginseng RecoveryCreampanax ginseng root water, acetyl glucosamine, dimethyl sulfone | Dimethyl sulfone .1 g/100mL + 2 more ingredients | CreamTopical | Power Fulx Co., Ltd. | Unapproved drug (other) | 70042-0004 | 70042-0004-0170042-0004-0270042-0004-03+1 more | — |
| PowerfulX RecoveryCreamacetyl glucosamine, dimethyl sulfone | Dimethyl sulfone .02 g/100mL; N-acetylglucosamine .02 g/100mL | CreamTopical | Power Fulx Co., Ltd. | Unapproved drug (other) | 70042-0007 | 70042-0007-0170042-0007-0270042-0007-03+3 more | — |
| PowerSpot Cleansesulfur | Sulfur 30 mg/mL | SoapTopical |
| Bluemercury |
| OTC monograph drug |
| 72203-014 |
| 72203-0014-0172203-0014-02 |
| — |
| Prmenthol | Menthol .5 g/100g | LotionTopical | Amphp, Inc | OTC monograph drug | 72358-101 | 72358-0101-0372358-0101-04 | — |
|---|
| Practical Alchemy Hydrating SPF 30zinc oxide | Zinc oxide 14.6 g/100g | CreamTopical | Over Here, LLC | OTC monograph drug | 84994-001 | 84994-0001-02 | — |
|---|
| Practical Alchemy Purify and Protect Duomicellar water wipes and zinc oxide | — | KitTopical | Over Here, LLC | OTC monograph drug | 84994-002 | 84994-0002-15 | — |
|---|
| Prada Reveal Skin Optimizing Foundation Broad Spectrum SPF 17 Sunscreenensulizole | Ensulizole 27 mg/mL | LiquidTopical | L'Oreal USA Products Inc | OTC monograph drug | 49967-380 | 49967-0380-0149967-0380-0249967-0380-03+1 more | — |
|---|
| Prada Reveal Skin Optimizing Foundation Broad Spectrum SPF 17 Sunscreenensulizole | Ensulizole 27 mg/mL | LiquidTopical | SICOS ET CIE | OTC monograph drug | 51150-380 | 51150-0380-0151150-0380-0251150-0380-03+1 more | — |
|---|
| Pradaxadabigatran etexilate mesylate | Dabigatran etexilate mesylate 110 mg/1 | CapsuleOral | Boehringer Ingelheim Pharmaceuticals Inc. | NDA | 0597-0108 | 00597-0108-5400597-0108-60 | — |
|---|
| Pradaxadabigatran etexilate mesylate | Dabigatran etexilate mesylate 75 mg/1 | CapsuleOral | Boehringer Ingelheim Pharmaceuticals Inc. | NDA | 0597-0355 | 00597-0355-0900597-0355-56 | — |
|---|
| Pradaxadabigatran etexilate mesylate | Dabigatran etexilate mesylate 150 mg/1 | CapsuleOral | Boehringer Ingelheim Pharmaceuticals Inc. | NDA | 0597-0360 | 00597-0360-5500597-0360-82 | — |
|---|
| Pradaxadabigatran etexilate | Dabigatran etexilate mesylate 20 mg/1 | PelletOral | Boehringer Ingelheim Pharmaceuticals, Inc. | NDA | 0597-0425 | 00597-0425-78 | — |
|---|
| Pradaxadabigatran etexilate | Dabigatran etexilate mesylate 30 mg/1 | PelletOral | Boehringer Ingelheim Pharmaceuticals, Inc. | NDA | 0597-0430 | 00597-0430-18 | — |
|---|
| Pradaxadabigatran etexilate | Dabigatran etexilate mesylate 40 mg/1 | PelletOral | Boehringer Ingelheim Pharmaceuticals, Inc. | NDA | 0597-0435 | 00597-0435-96 | — |
|---|
| Pradaxadabigatran etexilate | Dabigatran etexilate mesylate 50 mg/1 | PelletOral | Boehringer Ingelheim Pharmaceuticals, Inc. | NDA | 0597-0440 | 00597-0440-53 | — |
|---|
| Pradaxadabigatran etexilate | Dabigatran etexilate mesylate 110 mg/1 | PelletOral | Boehringer Ingelheim Pharmaceuticals, Inc. | NDA | 0597-0445 | 00597-0445-87 | — |
|---|
| Pradaxadabigatran etexilate | Dabigatran etexilate mesylate 150 mg/1 | PelletOral | Boehringer Ingelheim Pharmaceuticals, Inc. | NDA | 0597-0450 | 00597-0450-16 | — |
|---|
| Prairie Mugwort Darkleaved Sagebrushartemisia ludoviciana | Artemisia ludoviciana pollen .1 g/mL | SolutionIntradermal, Percutaneous, Subcutaneous | Greer Laboratories, Inc. | BLA | 22840-1349 | 22840-1349-0222840-1349-04 | — |
|---|
| Prairie Mugwort Darkleaved Sagebrushartemisia ludoviciana | Artemisia ludoviciana pollen 20000 [PNU]/mL | SolutionIntradermal, Percutaneous, Subcutaneous | Greer Laboratories, Inc. | BLA | 22840-1350 | 22840-1350-0222840-1350-04 | — |
|---|
| Prairie Mugwort Darkleaved Sagebrushartemisia ludoviciana | Artemisia ludoviciana pollen .001 g/mL | SolutionIntradermal, Percutaneous, Subcutaneous | Greer Laboratories, Inc. | BLA | 22840-1351 | 22840-1351-01 | — |
|---|
| Prairie Mugwort Darkleaved Sagebrushartemisia ludoviciana | Artemisia ludoviciana pollen .05 g/mL | SolutionIntradermal, Percutaneous, Subcutaneous | Greer Laboratories, Inc. | BLA | 22840-1352 | 22840-1352-0222840-1352-04 | — |
|---|
| Prairie Mugwort Darkleaved Sagebrushartemisia ludoviciana | Artemisia ludoviciana pollen 40000 [PNU]/mL | SolutionIntradermal, Percutaneous, Subcutaneous | Greer Laboratories, Inc. | BLA | 22840-1353 | 22840-1353-04 | — |
|---|
| Prairie Mugwort Darkleaved Sagebrushartemisia ludoviciana | Artemisia ludoviciana pollen .05 g/mL | SolutionIntradermal, Percutaneous, Subcutaneous | Greer Laboratories, Inc. | BLA | 22840-5315 | 22840-5315-0222840-5315-0422840-5315-05 | — |
|---|
| Pralatrexate | Pralatrexate 20 mg/mL | InjectionIntravenous | Dr.Reddy's Laboratories Inc., | ANDA | 43598-342 | 43598-0342-11 | — |
|---|
| Pralatrexate | Pralatrexate 40 mg/2mL | InjectionIntravenous | Dr.Reddy's Laboratories Inc., | ANDA | 43598-343 | 43598-0343-23 | — |
|---|
| Pralatrexate | Pralatrexate 20 mg/mL | InjectionIntravenous | Fresenius Kabi USA, LLC | NDA authorized generic | 65219-550 | 65219-0550-01 | — |
|---|
| Pralatrexate | Pralatrexate 40 mg/2mL | InjectionIntravenous | Fresenius Kabi USA, LLC | NDA authorized generic | 65219-552 | 65219-0552-02 | — |
|---|
| Praluentalirocumab | Alirocumab 75 mg/mL | Injection, SolutionSubcutaneous | Sanofi-Aventis U.S. LLC | BLA | 0024-5901 | 00024-5901-0000024-5901-01 | — |
|---|
| Praluentalirocumab | Alirocumab 150 mg/mL | Injection, SolutionSubcutaneous | Sanofi-Aventis U.S. LLC | BLA | 0024-5902 | 00024-5902-0000024-5902-01 | — |
|---|
| Praluentalirocumab | Alirocumab 75 mg/mL | Injection, SolutionSubcutaneous | Regeneron Pharmaceuticals, Inc. | BLA | 61755-020 | 61755-0020-0161755-0020-0261755-0020-04 | — |
|---|
| Praluentalirocumab | Alirocumab 150 mg/mL | Injection, SolutionSubcutaneous | Regeneron Pharmaceuticals, Inc. | BLA | 61755-021 | 61755-0021-0161755-0021-0261755-0021-04 | — |
|---|
| Pramipexole | Pramipexole dihydrochloride .125 mg/1 | TabletOral | Camber Pharmaceuticals, Inc. | ANDA | 31722-906 | 31722-0906-0531722-0906-1031722-0906-90 | — |
|---|
| Pramipexole | Pramipexole dihydrochloride .25 mg/1 | TabletOral | Camber Pharmaceuticals, Inc. | ANDA | 31722-907 | 31722-0907-0531722-0907-1031722-0907-90 | — |
|---|
| Pramipexole | Pramipexole dihydrochloride .5 mg/1 | TabletOral | Camber Pharmaceuticals, Inc. | ANDA | 31722-908 | 31722-0908-0531722-0908-1031722-0908-90 | — |
|---|
| Pramipexole | Pramipexole dihydrochloride .75 mg/1 | TabletOral | Camber Pharmaceuticals, Inc. | ANDA | 31722-909 | 31722-0909-0531722-0909-1031722-0909-90 | — |
|---|
| Pramipexole | Pramipexole dihydrochloride 1 mg/1 | TabletOral | Camber Pharmaceuticals, Inc. | ANDA | 31722-910 | 31722-0910-0531722-0910-1031722-0910-90 | — |
|---|
| Pramipexole | Pramipexole dihydrochloride 1.5 mg/1 | TabletOral | Camber Pharmaceuticals, Inc. | ANDA | 31722-911 | 31722-0911-0531722-0911-1031722-0911-90 | — |
|---|
| Pramipexole dihydrochloride | Pramipexole dihydrochloride .25 mg/1 | TabletOral | NCS HealthCare of KY, LLC dba Vangard Labs | ANDA | 0615-8551 | 00615-8551-39 | — |
|---|
| Pramipexole dihydrochloride | Pramipexole dihydrochloride .5 mg/1 | TabletOral | NCS HealthCare of KY, LLC dba Vangard Labs | ANDA | 0615-8552 | 00615-8552-39 | — |
|---|
| Pramipexole Dihydrochloride | Pramipexole dihydrochloride .25 mg/1 | TabletOral | Major Pharmaceuticals | ANDA | 0904-6704 | 00904-6704-61 | — |
|---|
| Pramipexole Dihydrochloride | Pramipexole dihydrochloride .125 mg/1 | TabletOral | Torrent Pharmaceuticals Limited | ANDA | 13668-091 | 13668-0091-0513668-0091-3013668-0091-42+1 more | — |
|---|
| Pramipexole Dihydrochloride | Pramipexole dihydrochloride .25 mg/1 | TabletOral | Torrent Pharmaceuticals Limited | ANDA | 13668-092 | 13668-0092-0513668-0092-3013668-0092-41+1 more | — |
|---|
| Pramipexole Dihydrochloride | Pramipexole dihydrochloride .5 mg/1 | TabletOral | Torrent Pharmaceuticals Limited | ANDA | 13668-093 | 13668-0093-0513668-0093-3013668-0093-40+1 more | — |
|---|
| Pramipexole Dihydrochloride | Pramipexole dihydrochloride 1 mg/1 | TabletOral | Torrent Pharmaceuticals Limited | ANDA | 13668-094 | 13668-0094-0513668-0094-3013668-0094-31+1 more | — |
|---|
| Pramipexole Dihydrochloride | Pramipexole dihydrochloride 1.5 mg/1 | TabletOral | Torrent Pharmaceuticals Limited | ANDA | 13668-095 | 13668-0095-0513668-0095-1513668-0095-30+1 more | — |
|---|
| Pramipexole Dihydrochloride | Pramipexole dihydrochloride .75 mg/1 | TabletOral | Torrent Pharmaceuticals Limited | ANDA | 13668-184 | 13668-0184-0513668-0184-3013668-0184-31+1 more | — |
|---|
| Pramipexole Dihydrochloride | Pramipexole dihydrochloride .375 mg/1 | Tablet, Extended releaseOral | NorthStar RxLLC | ANDA | 16714-916 | 16714-0916-01 | — |
|---|
| Pramipexole Dihydrochloride | Pramipexole dihydrochloride .75 mg/1 | Tablet, Extended releaseOral | NorthStar RxLLC | ANDA | 16714-917 | 16714-0917-01 | — |
|---|
| Pramipexole Dihydrochloride | Pramipexole dihydrochloride 1.5 mg/1 | Tablet, Extended releaseOral | NorthStar RxLLC | ANDA | 16714-918 | 16714-0918-01 | — |
|---|
| Pramipexole Dihydrochloride | Pramipexole dihydrochloride 2.25 mg/1 | Tablet, Extended releaseOral | NorthStar RxLLC | ANDA | 16714-919 | 16714-0919-01 | — |
|---|